# A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

> **NCT01259869** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 34 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** PX-866

## Key facts

- **NCT ID:** NCT01259869
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-01
- **Primary completion:** 2014-10-29
- **Final completion:** 2015-02-13
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259869, "A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01259869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*